Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock.

Naoki Tadokoro Satsuki Fukushima Kimito MinamiTakura TaguchiTetsuya SaitoNaonori KawamotoTakashi KakutaOsamu SeguchiTakuya WatanabeSeiko Nakajima DoiKensuke KurodaKeisuke SuzukiMasanobu YanaseYasuhide Asaumi Hideyuki ShimizuNorihide FukushimaTomoyuki Fujita

Published in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2021)

Conversion to central ECLS is feasible and safe in patients with fulminant myocarditis. Patients with severe myocardial injury as shown by a high creatine kinase-MB level, rhythm disturbance and aortic valve closure should be converted to a durable left ventricular assist device.

Keyphrases

aortic valve
left ventricular assist device
transcatheter aortic valve replacement
transcatheter aortic valve implantation
aortic valve replacement
aortic stenosis
liver failure
atrial fibrillation
early onset
heart rate
tyrosine kinase
left ventricular
hepatitis b virus